Sfoglia per Autore
Vascular smooth muscle and atherosclerosis: role of isoprenoids and calcium antagonists
1994 A. Corsini, M. Raiteri, V. Dimitri, E. Donetti, M. Soma, F. Bernini, R. Fumagalli, R. Paoletti
Lacidipine - in vivo effects on intimal carotid thickening in hypercholesterolemic rabbits
1994 M.R. Soma, C. Parolini, E. Donetti, C. Galli, R. Paoletti, R. Fumagalli
LACIDIPINE: IN VIVO EFFECTS ON INTIMAL CAROTID THICKENING IN HYPERCHOLESTEROLAEMIC RABBITS
1994 M.R. Soma, C. Parolini, E. Donetti, C. Galli, R. Paoletti, R. Fumagalli
Pharmacology of lipoprotein receptors
1994 F. Bernini, A. Corsini, R. Fumagalli, R. Paoletti
Experimental and clinical effects of isradipine relevant to atherosclerosis
1994 F. Bernini, M.R. Soma, A. Corsini, R. Paoletti
Direct drug control of the vascular wall
1995 R. Paoletti, F. Bernini, A. Corsini, M. Soma
Effect of 25-hydroxycholesterol, 26-hydroxycholesterol and its analogue, 26-aminocholesterol, on protein content, protein synthesis and LDH leakage in mouse epidermal cells
1995 M. Marinovich, M. Guizzetti, F. Ghilardi, R. Paoletti, C.L. Galli
Atherosclerosis and thrombosis. Old and new drugs
1995 R. Paoletti, F. Bruno, S. Colli
Inhibition of isoprenoid biosynthesis and arterial smooth muscle cell proliferation
1995 M.R. Soma, C. Parolini, E. Donetti, R. Fumagalli, R. Paoletti
Effects of 26-aminocholesterol, 27-hydroxycholesterol, and 25-hydroxycholesterol on proliferation and cholesterol homeostasis in arterial myocytes
1995 A. Corsini, D. Verri, M. Raiteri, P. Quarato, R. Paoletti, R. Fumagalli
Farmacologia delle statine: evidenze di un'azione antiaterosclerotica diretta
1995 M. Raiteri, L. Arnaboldi, P. Quarato, R. Paoletti, R. Fumagalli, A. Corsini
Mevalonate pathway and isoprenoids regulate human bronchial myocyte proliferation
1995 T. Viganõ, A. Hernandez, A. Corsini, A. Granata, P. Belloni, R. Fumagalli, R. Paoletti, G. Folco
Effect of lacidipine on fatty and proliferative lesions induced in hypercholesterolaemic rabbits
1996 M.R. Soma, E. Donetti, R. Seregni, L. Barberi, R. Fumagalli, R. Paoletti, A.L. Catapano
Inhibitor of proliferation of arterial smooth-muscle cells by fluvastatin
1996 A. CORSINI, F. PAZZUCCONI, P. PFISTER, R. PAOLETTI, C. SIRTORI
Non-lipid-related effects of 3-hydroxy-3-methylglutaryl coenzyme A Reductase inhibitors
1996 A. Corsini, F. Bernini, P. Quarato, E. Donetti, S. Bellosta, R. Fumagalli, R. Paoletti, M.R. Soma
EFFECT OF THE NEW HMG-CoA REDUCTASE INHIBITOR CERIVASTATIN (BAY W 6228) ON MIGRATION, PROLIFERATION AND CHOLESTEROL SYNTHESIS IN ARTERIAL MYOCYTES
1996 A.Corsini, L. Arnaboldi, M. Raiteri, P. Quarato, A. Faggiotto, R. Paoletti, R. Fumagalli
Relation between hemostatic variables and increase of common carotid intima-media thickness in patients with peripheral arterial disease
1996 M. Cortellaro, D. Baldassarre, E. Cofrancesco, E. Tremoli, A. Colombo, C. Boschetti, R. Paoletti
Vastatin inhibit tissue factor expression by human macrophages
1997 S. Colli, M. Lalli, S. Eligini, M. Camera, R. Paoletti, E. Tremoli
Pharmacological control of the mevalonate pathway in the regulation of arterial myocyte proliferation
1997 A. Corsini, L. Arnaboldi, P. Mcgeady, M.H. Gelb, P. Quarato, C. Tagliabue, N. Ferri, R. Paoletti, R. Fumagalli
Pharmacological control of protein prenylation and arterial smooth muscle cell proliferation
1997 P. Quarato, L. Arnaboldi, N. Ferri, J. Seboltleopold, R. Paoletti, R. Fumagalli, A. Corsini
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile